About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1122 record(s)
Req # A-2020-00344
Docket 187078: Meeting between Minister of Natural Resources and the Chemistry Industry Association of Canada (CIAC) (Bob Masterson).Organization: Natural Resources Canada
October 2020
Req # A-2020-00345
Docket 187130: Meeting with Clean Energy Canada.Organization: Natural Resources Canada
October 2020
Req # A-2020-00164
Docket 187058: Meeting Between the Deputy Minister of Natural Resources and Deputy Minister of Environment and Climate Change Canada.Organization: Natural Resources Canada
October 2020
Req # A-2020-00121
Docket 184863: Meeting between Deputy Minister of Natural Resources and the Clerk of the Privy Council on Engagement with the West on Energy and the Environment.Organization: Natural Resources Canada
October 2020
Nothing to report this month
Organization: Canadian Centre for Occupational Health and Safety
Req # A-2019-000354
All correspondence between FSD Pharma Inc. and Heath Canada from August 1, 2018 to June 4, 2019 regarding an application(s) for or issuing of any license(s) or permit(s).Organization: Health Canada
April 2020
Req # A-2019-000440
Any correspondence between any representative of Health Canada and any representative of Purdue Pharmaceutical or Purdue Pharma in regards to adverse reactions of OxyContin, including the adverse reaction of death.Organization: Health Canada
April 2020
Req # A-2019-000441
Any correspondence between Health Canada and any representative of Purdue Pharmaceutical in regards to any deceptive or manipulative marketing practices by the company in the sales of any of its products, in particular, of OyxContin by Purdue…Organization: Health Canada
April 2020
Req # A-2019-000958
All documents related to the natural health product licence submission, assessment, and decision for Ovomet.Organization: Health Canada
April 2020
Req # A-2019-001646
Adverse Reaction Report (AER) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report number: E2B_02372540.Organization: Health Canada
April 2020